Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Department of Surgery, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, the Netherlands.
Br J Surg. 2023 Apr 12;110(5):599-605. doi: 10.1093/bjs/znad057.
The risk of death after surgery for perihilar cholangiocarcinoma is high; nearly one in every five patients dies within 90 days after surgery. When the oncological benefit is limited, a high-risk resection may not be justified. This retrospective cohort study aimed to create two preoperative prognostic models to predict 90-day mortality and overall survival (OS) after major liver resection for perihilar cholangiocarcinoma.
Separate models were built with factors known before surgery using multivariable regression analysis for 90-day mortality and OS. Patients were categorized in three groups: favourable profile for surgical resection (90-day mortality rate below 10 per cent and predicted OS more than 3 years), unfavourable profile (90-day mortality rate above 25 per cent and/or predicted OS below 1.5 years), and an intermediate group.
A total of 1673 patients were included. Independent risk factors for both 90-day mortality and OS included ASA grade III-IV, large tumour diameter, and right-sided hepatectomy. Additional risk factors for 90-day mortality were advanced age and preoperative cholangitis; those for long-term OS were high BMI, preoperative jaundice, Bismuth IV, and hepatic artery involvement. In total, 294 patients (17.6 per cent) had a favourable risk profile for surgery (90-day mortality rate 5.8 per cent and median OS 42 months), 271 patients (16.2 per cent) an unfavourable risk profile (90-day mortality rate 26.8 per cent and median OS 16 months), and 1108 patients (66.2 per cent) an intermediate risk profile (90-day mortality rate 12.5 per cent and median OS 27 months).
Preoperative risk models for 90-day mortality and OS can help identify patients with resectable perihilar cholangiocarcinoma who are unlikely to benefit from surgical resection. Tailored shared decision-making is particularly essential for the large intermediate group.
肝门部胆管癌患者术后的死亡风险较高,每 5 名患者中就有近 1 人在术后 90 天内死亡。当肿瘤学获益有限时,高风险的切除术可能并不合理。本回顾性队列研究旨在建立两种术前预后模型,以预测肝门部胆管癌行大范围肝切除术后 90 天死亡率和总生存期(OS)。
使用多变量回归分析,针对 90 天死亡率和 OS 分别建立术前已知因素的模型。根据手术切除的预后情况将患者分为三组:手术切除的有利预后组(90 天死亡率低于 10%,预测 OS 超过 3 年)、不利预后组(90 天死亡率高于 25%和/或预测 OS 低于 1.5 年)和中间组。
共纳入 1673 例患者。90 天死亡率和 OS 的独立危险因素包括 ASA 分级 III-IV 级、肿瘤直径较大和右半肝切除术。90 天死亡率的其他危险因素包括高龄和术前胆管炎;长期 OS 的危险因素包括高 BMI、术前黄疸、Bismuth Ⅳ型和肝动脉受累。共有 294 例(17.6%)患者手术风险有利(90 天死亡率 5.8%,中位 OS 42 个月),271 例(16.2%)患者风险不利(90 天死亡率 26.8%,中位 OS 16 个月),1108 例(66.2%)患者风险中等(90 天死亡率 12.5%,中位 OS 27 个月)。
术前 90 天死亡率和 OS 风险模型有助于识别出可能无法从手术切除中获益的可切除肝门部胆管癌患者。对于较大的中间组,有针对性的共同决策尤为重要。